Signal Genetics Inc  

(Public, NASDAQ:SGNL)   Watch this stock  
Find more results for SGNL
9.07
-1.18 (-11.51%)
Jan 18 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 9.06 - 10.93
52 week 1.80 - 17.74
Open 10.33
Vol / Avg. 17,032.00/74,826.00
Mkt cap 6.75M
P/E     -
Div/yield     -
EPS -14.10
Shares 742,293.00
Beta     -
Inst. own 6%

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -206.86% -446.34%
Operating margin -204.27% -440.78%
EBITD margin - -433.53%
Return on average assets -88.96% -107.93%
Return on average equity -132.63% -138.14%
Employees 32 -
CDP Score - -

Address

5740 Fleet St
CARLSBAD, CA 92008-4708
United States - Map
+1-760-5374100 (Phone)
+1-212-3193328 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Signal Genetics, Inc. is a commercial stage, molecular genetic diagnostic company. The Company is focused on providing diagnostic services that help physicians to make decisions concerning the care of cancer patients. The Company's diagnostic service is the Myeloma Prognostic Risk Signature (MyPRS) test. The MyPRS test is a microarray-based gene expression profile (GEP), assay that measures the expression level of specific genes and groups of genes that are designed to predict an individual's long-term clinical outcome/prognosis, giving a basis for personalized treatment options. The Company's MyPRS test provides a whole-genomic expression profile of a patient's multiple myeloma (MM). The Company offers MyPRS test in its laboratory located in Little Rock, Arkansas. The Company is licensed to sell its test in all 50 states.

Officers and directors

Bennett S. LeBow Chairman of the Board
Age: 78
Bio & Compensation  - Reuters
Samuel D. Riccitelli President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Tamara A. Seymour Chief Financial Officer
Age: 56
Bio & Compensation  - Reuters
Sudipto Ph.D. Sur Chief Information Officer
Bio & Compensation  - Reuters
Richard Bender M.D. Chief Medical Officer
Bio & Compensation  - Reuters
David A Gonyer Independent Director
Age: 51
Bio & Compensation  - Reuters
Douglas A. Schuling Independent Director
Age: 54
Bio & Compensation  - Reuters
Robin L. Smith M.D. Independent Director
Age: 51
Bio & Compensation  - Reuters